+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

European Artificial Tears Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: Europe
  • Orion Market Research Private Limited
  • ID: 4901044
The European artificial tears market is estimated to grow modestly, at a CAGR of around 4.2%, during the forecast period. Europe has a huge potential for the growth in the artificial tears market owing to the prevalence of cataracts and other eye diseases. As the number of cataract surgeries increases in the region, the demand for artificial tears for post-surgical use is expected to increase significantly in the coming years. This is expected to promote the growth of the market in Europe during the forecast period.

UK, Spain, Germany, France, and Italy are the major economies of Europe that are contributing significantly towards the growth of the European artificial tears market. The European market is driven by numerous factors including the increasing average age of the population. Europe is a fully developed region in terms of technological advancement. According to the Eurostat, in 2017, approximately 19%, one-fifth of the EU population was aged 65 and over. Moreover, by 2080, the proportion of people aged 80 and over should more than double to reach 13% of the total population. In 2017, the population in the EU-28 was estimated at 511.5 million. Among this population, the young people (0-14 age group) consist of 15.6% of the total EU-28 population.

The companies which are contributing to the growth of the European artificial tears market include Carl Zeiss Meditec AG, Essilor Group, Novartis International AG, Shire PLC, and Ziemer Ophthalmic Systems AG. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instance, in September 2018, Santen Pharmaceutical Co., Ltd. established a broad-based multi-target discovery and development agreement with PeptiDream Inc. Under this partnership, PeptiDream will be using its proprietary Peptide Discovery Platform System (PDPS) technology for identifying macrocyclic/constrained peptides against multiple ophthalmic disease targets of interest selected by Santen and to optimize hit peptides into therapeutic peptides products for such indications.

Research Methodology

The market study of the European artificial tears market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for drug manufacturers, healthcare providers, government organizations for overall market analysis, and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. European Artificial Tears Market Research and Analysis by Type
2. European Artificial Tears Market Research and Analysis by Delivery Method
3. European Artificial Tears Market Research and Analysis by Application

The Report Covers:
  • Comprehensive research methodology of the European artificial tears market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the European artificial tears market.
  • Insights about market determinants which are stimulating the European artificial tears market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Country
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. European Artificial Tears Market by Type
5.1.1. Cellulose Derived Tears
5.1.2. Glycerin Derived Tears
5.1.3. Oil-Based Emulsion Tears
5.2. European Artificial Tears Market by Delivery Method
5.2.1. Artificial Eye Drops
5.2.2. Ointments
5.3. European Artificial Tears Market by Application
5.3.1. Dry Eyes Treatment
5.3.2. Contact Lens Moisture
5.3.3. Others
6. Regional Analysis
6.1. UK
6.2. Germany
6.3. Italy
6.4. France
6.5. Spain
6.6. Rest of Europe
7. Company Profiles
7.1. Carl Zeiss Meditec AG
7.2. Essilor Group
7.3. Haag-Streit Group
7.4. Nicox S.A.
7.5. Novaliq GmbH
7.6. NovaMedica LLC
7.7. Novartis International AG
7.8. Shire PLC
7.9. Sylentis S.A.
7.10. TopiVert Pharma Ltd.
7.11. URSAPHARM Arzneimittel GmbH
7.12. VISUfarma B.V.
7.13. Ziemer Ophthalmic Systems AG

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Carl Zeiss Meditec AG
  • Essilor Group
  • Haag-Streit Group
  • Nicox S.A.
  • Novaliq GmbH
  • NovaMedica LLC
  • Novartis International AG
  • Shire PLC
  • Sylentis S.A.
  • TopiVert Pharma Ltd.
  • URSAPHARM Arzneimittel GmbH
  • VISUfarma B.V.
  • Ziemer Ophthalmic Systems AG